Inventor · disambiguated record
Ravindra Majeti
Also filed as: MAJETI RAVINDRA
45 granted patents·26 pending applications·600 citations·filing 2009–2024
98Inventor score
Files withUNIV LELAND STANFORD JUNIOR62FORTY SEVEN INC2ALIZADEH ARASH ASH1CHAN ZUCKERBERG BIOHUB INC1CHAO MARK P1
Top patents by PatentIndex Score
71 records- 0199US8361736B2Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2010·Granted Jan 29, 2013·50 cites·8 claims
- 0298US11518806B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Dec 6, 2022·6 cites·34 claims
- 0398US11377495B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jul 5, 2022·7 cites·7 claims
- 0498US11072655B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Jul 27, 2021·6 cites·3 claims
- 0598US9796781B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 24, 2017·16 cites·2 claims
- 0698US9493575B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Nov 15, 2016·48 cites·7 claims
- 0798US9399682B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jul 26, 2016·38 cites·7 claims
- 0898US9382320B2Humanized and chimeric monoclonal antibodies to CD47UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jul 5, 2016·36 cites·8 claims
- 0998US9017675B2Humanized and chimeric monoclonal antibodies to CD47UNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Apr 28, 2015·66 cites·8 claims
- 1098US8709429B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Apr 29, 2014·30 cites·12 claims
- 1197US11136391B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 5, 2021·9 cites·17 claims
- 1297US9765143B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Sep 19, 2017·17 cites·10 claims
- 1397US9624305B2Methods of manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Apr 18, 2017·17 cites·3 claims
- 1497US9611329B2Methods of manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Apr 4, 2017·19 cites·3 claims
- 1597US9605076B2Methods of manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Mar 28, 2017·19 cites·3 claims
- 1696US11603404B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Mar 14, 2023·3 cites·36 claims
- 1796US11141480B2Dosing parameters for CD47 targeting therapies to hematologic malignanciesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Oct 12, 2021·9 cites·6 claims
- 1896US9623079B2Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Apr 18, 2017·26 cites·12 claims
- 1996US9193955B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Nov 24, 2015·10 cites·4 claims
- 2096US8758750B2Synergistic anti-CD47 therapy for hematologic cancersWEISSMAN IRVING L·Filed 2010·Granted Jun 24, 2014·50 cites·8 claims
- 2196US8562997B2Methods of treating acute myeloid leukemia by blocking CD47JAISWAL SIDDHARTHA·Filed 2010·Granted Oct 22, 2013·93 cites·2 claims
- 2295US10662242B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 26, 2020·6 cites·1 claims
- 2394US10301387B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 28, 2019·11 cites·15 claims
- 2494US2025333502A1Methods for Manipulating Phagocytosis Mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 2591US11807684B2Humanized and chimeric monoclonal antibodies to CD47UNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Nov 7, 2023·1 cites·9 claims
- 2689US2024092900A1Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 2788US10995152B2Modified immunoglobulin hinge regions to reduce hemagglutinationUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 4, 2021·2 cites·2 claims
- 2888US2024084006A1Humanized and chimeric monoclonal antibodies to cd47UNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 2986US12258403B2Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 3085US12194093B2Dosing parameters for CD47 targeting therapies to hematologic malignanciesUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Jan 14, 2025·0 cites·6 claims
- 3185US10087257B2SIRP alpha-antibody fusion proteinsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 2, 2018·3 cites·14 claims
- 3284US11773165B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Oct 3, 2023·0 cites·33 claims
- 3384US2022267439A1Methods for Manipulating Phagocytosis Mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 3482US10487150B2SIRP alpha-antibody fusion proteinsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Nov 26, 2019·1 cites·15 claims
- 3581US12162939B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Dec 10, 2024·0 cites·4 claims
- 3681US11780918B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Oct 10, 2023·0 cites·16 claims
- 3780US12258399B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Mar 25, 2025·0 cites·18 claims
- 3880US11718670B2Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancerUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Aug 8, 2023·0 cites·14 claims
- 3980US2025066473A1Treatment of cancer with combinations of immunoregulatory agentsUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 4079US2023406923A1Methods for determining and achieving therapeutically effective doses of anti-cd47 agents in treatment of cancerUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 4178US11760800B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Sep 19, 2023·0 cites·16 claims
- 4277US12274746B2Dosing parameters for CD47 targeting therapies to hematologic malignanciesUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Apr 15, 2025·0 cites·11 claims
- 4377US11014985B2Humanized and chimeric monoclonal antibodies to CD47UNIV LELAND STANFORD JUNIOR·Filed 2020·Granted May 25, 2021·0 cites·36 claims
- 4475US2020377591A1Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 4573US11104731B2Compositions for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Aug 31, 2021·0 cites·2 claims
- 4673US2019233515A1Methods for Manipulating Phagocytosis Mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2019·Application pending·0 cites
- 4771US11760810B2Modified immunoglobulin hinge regions to reduce hemagglutinationUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Sep 19, 2023·0 cites·5 claims
- 4871US2021214437A1Synergistic anti-cd47 therapy for hematologic cancersUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 4970US10640561B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 5, 2020·0 cites·4 claims
- 5070US10040862B2Humanized and chimeric monoclonal antibodies to CD99UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Aug 7, 2018·1 cites·11 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →